ID: ALA1916198

Max Phase: Preclinical

Molecular Formula: C136H224N40O39S

Molecular Weight: 3075.60

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)O

Standard InChI:  InChI=1S/C136H224N40O39S/c1-67(2)56-89(168-119(200)85(41-46-100(140)179)165-132(213)108(75(15)177)176-110(191)74(14)154-130(211)98(66-216)174-121(202)87(43-48-104(184)185)164-131(212)107(72(11)12)175-122(203)88(44-49-105(186)187)163-124(205)90(57-68(3)4)169-120(201)86(42-47-103(182)183)156-109(190)73(13)153-112(193)78-36-26-52-148-78)123(204)160-81(37-27-53-149-134(142)143)113(194)158-83(39-29-55-151-136(146)147)117(198)170-93(61-76-30-18-16-19-31-76)111(192)152-65-102(181)155-96(64-106(188)189)129(210)159-80(35-23-25-51-138)116(197)166-91(58-69(5)6)125(206)172-95(63-101(141)180)128(209)171-94(62-77-32-20-17-21-33-77)127(208)161-82(38-28-54-150-135(144)145)114(195)162-84(40-45-99(139)178)118(199)157-79(34-22-24-50-137)115(196)167-92(59-70(7)8)126(207)173-97(133(214)215)60-71(9)10/h16-21,30-33,67-75,78-98,107-108,148,177,216H,22-29,34-66,137-138H2,1-15H3,(H2,139,178)(H2,140,179)(H2,141,180)(H,152,192)(H,153,193)(H,154,211)(H,155,181)(H,156,190)(H,157,199)(H,158,194)(H,159,210)(H,160,204)(H,161,208)(H,162,195)(H,163,205)(H,164,212)(H,165,213)(H,166,197)(H,167,196)(H,168,200)(H,169,201)(H,170,198)(H,171,209)(H,172,206)(H,173,207)(H,174,202)(H,175,203)(H,176,191)(H,182,183)(H,184,185)(H,186,187)(H,188,189)(H,214,215)(H4,142,143,149)(H4,144,145,150)(H4,146,147,151)/t73-,74-,75+,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,107-,108-/m0/s1

Standard InChI Key:  RMEXGMNRSYUMOG-XSPLVYNSSA-N

Associated Targets(Human)

Apoptosis regulator Bcl-X 2604 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SU-DHL10 113 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SU-DHL-6 338 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 3075.60Molecular Weight (Monoisotopic): 3073.6495AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Goreshnik I, Brock AM, Maly DJ..  (2011)  Biochemical and pharmacological profiling of the pro-survival protein Bcl-xL.,  21  (17): [PMID:21807512] [10.1016/j.bmcl.2011.06.134]
2. Richard DJ, Lena R, Bannister T, Blake N, Pierceall WE, Carlson NE, Keller CE, Koenig M, He Y, Minond D, Mishra J, Cameron M, Spicer T, Hodder P, Cardone MH..  (2013)  Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker.,  21  (21): [PMID:23993674] [10.1016/j.bmc.2013.08.017]

Source